Guoyuan Securities
Search documents
孔雀东南飞:关于企业出海的一切(下)
Guoyuan Securities· 2024-02-21 16:00
Export Trends - Southeast Asia's export share has shown a steady increase, reaching 25% in recent years[1] - The export share to the United States has fluctuated, currently standing at 20%[1] - The export share to the European Union is at 15%, indicating a competitive market presence[1] Industry Performance - The energy equipment and services sector has a gross margin of 11.23% and a net margin of 2.28%[6] - The oil, gas, and consumable fuels sector boasts a gross margin of 22.43% and a net margin of 6.84%[6] - The chemical industry has a gross margin of 18.94% and a net margin of 9.00%[6] Investment Insights - The leasing and services industry holds a significant portion of foreign direct investment stock, indicating robust growth potential[2] - The transportation infrastructure sector has a gross margin of 28.00% and a net margin of 21.07%, reflecting strong profitability[6] - The healthcare technology sector shows a gross margin of 59.69% and a net margin of 18.17%, highlighting its lucrative nature[6]
首次覆盖报告:今世有缘,有缘相聚
Guoyuan Securities· 2024-02-21 16:00
[Table_Main] 公司研究|日常消费|食品、饮料与烟草 证券研究报告 今世缘(603369)公司首次覆盖报告 2024年02月21日 [Table_Title] 今世有缘,有缘相聚 [Table_ 买Inves 入t] |首次推荐 ——今世缘(603369)首次覆盖报告 [报Ta告bl要e_点Su:m mary] [基Ta本bl数e_据Ba se] 今世缘:苏酒优秀代表 52周最高/最低价(元):6 6.35 / 42.12 江苏今世缘酒业股份有限公司位于江苏省涟水县高沟镇,地处淮河名酒带,其 前身国营高沟酒厂出产的“高沟”酒是江苏名酒“三沟一河”的代表之一,公 A股流通股(百万股): 1254.50 司于 2014 年在上交所上市。2022 年,公司实现营业总收入 78.88 亿元 A股总股本(百万股): 1254.50 (+23.09%),归母净利 25.03 亿元(+23.34%)。公司实控人为涟水县人民政 流通市值(百万元): 62549.37 府,截至23H1,控制公司44.72%股权。 产能扩张中,产品结构优且不断升级 总 市值(百万元): 62549.37 1)公司产能建设持续推 ...
当LM曲线不再移动:关于LPR的调降
Guoyuan Securities· 2024-02-20 16:00
[Table_Title] 宏观研究报告 证券研究报告 这次 LPR 利率的调降是有的放矢的,专门调降了更长的 5 年期 LPR, 而偏短期限的 1 年期 LPR 没有动。 况且,这种长期利率的定向调降若有效果,其先决条件是实体部门有货 币收紧的预期,感性看,这个货币收紧的预期几乎不存在。 | --- | --- | --- | |--------------------------|---------|-------| | | | | | [Table_Index] 主要数据: | | | | 上证综指: | 2922.73 | | | | | | | 深圳成指: | 8905.96 | | | 沪深 300 : | 3410.85 | | | 中小盘指: | 3309.70 | | | 创业板指: | 1746.18 | | | --- | --- | |------------------------|------------------------| | | | | [Table_Author 报告作者 | ] | | 分析师 | 杨为敩 | | 执业证书编号 | S0020521060001 | | ...
通信行业周报:Sora及Gemini 1.5发布,大模型能力涌现
Guoyuan Securities· 2024-02-18 16:00
[Table_Main] 行 业研究|电信服务 证 券研究报告 电信服务行业周报 2024年02月19日 [Table_Invest] [Table_Title] 推荐|维持 Sora 及 Gemini 1.5 发布,大模型能力涌现 ——通信行业周报 [过Ta去bl一e_年Pic市Q场uo行te]情 [报Ta告ble要_S点um:m ary] OpenAI Sora的技术细节:是数据驱动物理引擎 沪深300 通信(申万) 此前,我们已经见证过许多创业公司提出的视频生成模型。相比之下, 50% OpenAI 提出的新模型不论是效果还是理念上,似乎都具有划时代的 40% 30% 意义。有人第一时间总结道,Sora 不是一个简单的视频生成器,它是 20% 10% 一个数据驱动的物理引擎,其对于虚拟和现实世界进行模拟。在这个 0% 过程中,模拟器通过一些去噪和梯度数学方法来学习复杂的视觉渲染, -10% -20% 构建出「直观」的物理效果,以及进行长期推理和语义基础。 -30%2/18 5/18 8/18 11/18 2/18 在 Sora 推出后,OpenAI 很快公布了技术报告: 资料来源:Wind,国元证券 ...
公司首次覆盖报告:Dram行业三点共振,新业务切入AI算力系统
Guoyuan Securities· 2024-02-07 16:00
[Table_Main] 公司研究|信息技术|半导体与半导体生 产设备 证券研究报告 澜起科技(688008)公司首次覆盖 2024年02月07日 报告 [Table_Invest] [T Dab rle a_T mitle 行] 买入|首次推荐 业三点共振,新业务切入 AI 算力系统 ——澜起科技(688008)公司首次覆盖报告 [当Ta前b价le_/目Ta标rg价etP:r 4ic8e.7] 0元/65元 [报Ta告ble要_S点um:m ary] 目标期限: 6 个月 24年Dram行业“三点共振”,有望形成重构估值 [基Ta本bl数e_据Ba se] 2024 年是Dram行业“三点共振”的交汇时点。三点共振指的是 Dram行业 52周最高/最低价(元): 76.46 / 44.59 经过了2年调整后,将在24年迎来大周期向上拐点,DDR5在全球Dram市 A股流通股(百万股): 1141.46 场渗透率从23年的15%左右提升到50%-60%的关键时点,以及AI+率先带动 A股总股本(百万股): 1141.46 的AI PC需求,进而推动消费类 Dram规格向服务器Dram规格靠拢的关键 流通市 ...
首次覆盖报告:多元化疾病领域布局特色品种的创新药企,未来可期
Guoyuan Securities· 2024-02-07 16:00
[Table_Main] 公司研究|医疗保健|制药、生物科技与生命科学 证券研究报告 吉贝尔(688566)公司首次覆盖报 告2024 年 02 月 05 日 [Table_Title] 多元化疾病领域布局特色品种的创新药 企,未来可期 ——吉贝尔(688566.SH)首次覆盖报告 [Table_Summary] 报告要点: 公司是多元化疾病领域布局的创新药企,2023 年业绩高增 公司是以升白药物利可君片、抗高血压复方一类新药尼群洛尔片等高新技 术产品为主的特色创新药企,致力于抑郁症、肿瘤、胃病等的创新型药物的 研发。2023Q1-Q3 营收和扣非归母净利润分别同比增长 44.64%、124.59%。 利可君片:临床不可替代升白口服药优势品种,肿瘤领域应用前景可期 升白口服制剂在围放化疗期能够预防和治疗白细胞减少的临床不可替代性 为其建立了市场保护屏障。利可君被《临床路径释义·肿瘤疾病分册(2022 年版)》作为治疗恶性肿瘤疾病的推荐用药收录在册。此外,利可君片可在 化疗前期和后期弥补生物注射制剂用药时机有限、副作用明显的短板,且不 影响放化疗的效果,与生物制剂不构成竞品关系,是临床上最常用的联用药 物。2 ...
江苏神通2023年度业绩预告点评:核阀订单有序兑现,业绩发展稳中向好
Guoyuan Securities· 2024-02-05 16:00
Investment Rating - The report maintains a "Buy" rating for Jiangsu Shentong (002438) [3][6] Core Views - The company is expected to achieve stable growth in performance due to steady growth in traditional business and the opening up of new business areas, particularly in the nuclear power sector [5][12] - Revenue projections for 2023-2025 are estimated at 2.1 billion, 2.5 billion, and 3.1 billion yuan respectively, with net profit attributable to shareholders expected to be 266 million, 347 million, and 460 million yuan respectively [6][14] Summary by Sections Investment Suggestions and Profit Forecast - The company is projected to benefit from an increase in nuclear power valve delivery volumes, leading to stable growth in Q4 performance [12] - The expected net profit for 2023 is between 250 million and 284 million yuan, representing a year-on-year growth of 10% to 25% [12] Financial Data and Valuation - The company’s revenue is forecasted to grow at a compound annual growth rate (CAGR) of approximately 20.45% from 2021 to 2025 [14] - The estimated earnings per share (EPS) for 2023, 2024, and 2025 are projected to be 0.52, 0.68, and 0.91 yuan respectively, with corresponding price-to-earnings (P/E) ratios of 15.89, 12.20, and 9.20 [6][14] Business Outlook - The company is positioned as a leading supplier of nuclear valves in China, with a high bid-winning rate of over 90% in the past decade [13] - New business areas, such as hydrogen energy and semiconductor-related products, are expected to gradually contribute to performance as they move through testing and validation phases [13]
2023年度业绩预告点评:业绩基本符合预期,工控新品实现量产
Guoyuan Securities· 2024-02-05 16:00
Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 20% compared to the Shanghai Composite Index within the next six months [5][7]. Core Views - The company is projected to achieve a net profit attributable to shareholders of 310-349 million yuan for the year 2023, representing a year-on-year growth of 20%-35%. The non-recurring profit impact on net profit is estimated to be 25-35 million yuan, primarily due to foreign exchange hedging and product sales structure optimization [1][10]. - The company has successfully launched new industrial control products into mass production, including ball screw products and small-batch supply of hollow cup motors. The R&D progress is promising, with expectations for continued growth in high-end industrial control products [2][10]. - Financial forecasts indicate that the company will generate revenues of 3.46 billion yuan in 2023, with a projected net profit of 341 million yuan, and an EPS of 1.08 yuan per share, with a PE ratio of 18.00 [3][10]. Financial Data and Valuation - Revenue for 2023 is expected to be 3,461.33 million yuan, with a year-on-year growth of 19.36%. The net profit attributable to shareholders is projected at 341.28 million yuan, reflecting a year-on-year increase of 31.91% [3][10]. - The company’s return on equity (ROE) is forecasted to be 10.50% in 2023, with an increasing trend expected in subsequent years [3][10]. - The company’s market capitalization is approximately 5,982.31 million yuan, with a circulating market value of 5,982.31 million yuan [4]. Product Development and Market Position - The company is recognized as a leader in the micro-motor sector, with a diverse business portfolio spanning home appliances, automotive, and medical industries. The strong performance and R&D capabilities position the company favorably for long-term growth [10]. - The company has made significant advancements in high-end industrial control products, including breakthroughs in micro-special motors and intelligent components, which are expected to expand into high-end applications such as laser cutting [2][10].
首次覆盖报告:“大品牌、小品类”研产销一体,发力婴童护理
Guoyuan Securities· 2024-02-03 16:00
Investment Rating - The report gives an "Accumulate" rating for the company, Runben Co., Ltd. [27] Core Viewpoints - Runben Co., Ltd. focuses on "big brand, small categories," specializing in mosquito repellent and personal care products, with strong financial performance [17] - The mosquito repellent market is expected to exceed 10 billion yuan by 2027, driven by high-margin new products [18] - The company has achieved impressive revenue and net profit growth, with a projected net profit increase of 34.34% to 46.83% in 2023 [83] Summary by Sections Company Overview - Runben Co., Ltd. was established in 2006 and has evolved through three stages: initial establishment, strategic layout, and rapid development [69] - The company has a strong focus on online sales, having established its first Tmall store in 2010 and expanded to multiple e-commerce platforms [69][71] Financial Analysis - The company reported a revenue of 856 million yuan in 2022, a year-on-year increase of 47.06%, with a CAGR of 45.38% from 2019 to 2022 [83] - The net profit for 2022 was 160 million yuan, reflecting a year-on-year growth of 32.66% [83] Industry Analysis - The mosquito repellent market is characterized by strong demand and steady growth, with new high-margin products contributing significantly to market expansion [18] - The baby care market in China is projected to grow at a CAGR of 15%, reaching nearly 100 billion yuan by 2026 [7] Business Strategy - The company employs a C2M model, integrating research, production, and sales, with a focus on self-owned supply chains and online channels [18][71] - Runben's product strategy emphasizes new mosquito repellent products and the expansion into baby care, with a focus on high cost-performance [18] Profit Forecast and Investment Suggestions - The company is expected to achieve net profits of 224 million, 268 million, and 342 million yuan from 2023 to 2025, with corresponding EPS of 0.55, 0.66, and 0.85 yuan [27]
公司跟踪报告:分接开关龙头,持续突破海外、特高压、检修业务
Guoyuan Securities· 2024-02-01 16:00
Investment Rating - The report maintains a "Buy" rating for the company Huaming Equipment (002270.SZ) [1] Core Views - Huaming Equipment is a leading enterprise in transformer tap switches, focusing on three main business segments centered around electrical equipment. The company has shown steady growth, with a revenue of 1.712 billion yuan in 2022, representing a year-over-year increase of 11.7%. The net profit attributable to shareholders is expected to reach between 533 million and 560 million yuan in 2023, indicating a growth of 48.3% to 55.8% [2][3][24]. Summary by Sections Business Overview - Huaming Equipment has been deeply engaged in the transformer tap switch sector for 30 years and has established a leading position in the industry. The company acquired its main competitor, Changzheng Electric, in 2018, forming two major production bases and securing the top domestic and second global market share in tap switches [20][30]. Market Dynamics - The domestic market is experiencing an upturn in grid investment, which is expected to drive demand for transformers and their core components, including tap switches. The overseas market is also benefiting from accelerated grid investments, providing a broad outlook for the company's electrical equipment exports. The company is actively planning local operations abroad to capture market share from competitors [2][3][32]. Financial Forecast and Investment Rating - The company is projected to achieve net profits of 540 million, 660 million, and 830 million yuan for the years 2023, 2024, and 2025, respectively, with year-over-year growth rates of 50.5%, 22.0%, and 26.4%. The corresponding price-to-earnings ratios for these years are expected to be 23.6, 19.4, and 15.3, which are below the average of comparable companies, justifying the "Buy" rating [3][58]. Revenue and Profitability - The company’s revenue is expected to reach 2.146 billion, 2.642 billion, and 3.171 billion yuan for 2023, 2024, and 2025, respectively, with year-over-year growth rates of 25.4%, 23.1%, and 20.0%. The gross profit margins are projected to be 52.3%, 53.0%, and 53.4% for the same years [11][57]. Product and Service Expansion - Huaming Equipment is expanding its service offerings in maintenance and repair, leveraging its existing customer base of over 160,000 sold tap switches. The company is also focusing on high-barrier research and development for ultra-high voltage products, aiming to break the monopoly of foreign brands in this sector [3][54][81].